Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Megan Othus

Showing results (21-30 of 231) with videos related to

Pageof 24
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2024
Reverse Selection Designs for Accommodating Multiple Control ArmsSarah Samorodnitsky, Megan Othus, Michael LeBlanc, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 15, 2017
Accounting for Cured Patients in Cost-Effectiveness AnalysisMegan Othus, Aasthaa Bansal, Lisel Koepl, et al.
American Journal of Clinical Pathology|May 6, 2016
Clinical Experience With Modified, Single-Tube T-Cell Receptor Vβ Flow Cytometry Analysis for T-Cell ClonalityDavid Wu, Melanie M Anderson, Megan Othus, et al.
Bone Marrow Transplantation|August 27, 2022
Significance of measurable residual disease in adults with secondary acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantationEduardo Rodríguez-Arbolí, Corentin Orvain, Megan Othus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2012
Cure models as a useful statistical tool for analyzing survivalMegan Othus, Bart Barlogie, Michael L Leblanc, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 14, 2025
Designing Clinical Trials for Patients With Rare Cancers: Connecting the ZebrasVivek Subbiah, Megan Othus, Jim Palma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2020
Ipilimumab and Nivolumab in Rare Tumors S1609: Neuroendocrine-ResponseSandip P Patel, Megan Othus, Young Kwang Chae, et al.
Leukemia & Lymphoma|August 3, 2012
Influence of obesity on efficacy and toxicity of induction chemotherapy in patients with newly diagnosed acute myeloid leukemiaAndrew Lin, Megan Othus, Amy McQuary, et al.
Bone Marrow Transplantation|November 1, 2019
Statistics and measurable residual disease (MRD) testing: uses and abuses in hematopoietic cell transplantationMegan Othus, Robert Peter Gale, Christopher S Hourigan, et al.
International Journal of Radiation Oncology, Biology, Physics|July 8, 2010
Tumor volume is a prognostic factor in non-small-cell lung cancer treated with chemoradiotherapyBrian M Alexander, Megan Othus, Hale B Caglar, et al.
Pageof 24

Showing results (21-30 of 231) with videos related to

Sort By:
Pageof 24
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2024
Reverse Selection Designs for Accommodating Multiple Control ArmsSarah Samorodnitsky, Megan Othus, Michael LeBlanc, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 15, 2017
Accounting for Cured Patients in Cost-Effectiveness AnalysisMegan Othus, Aasthaa Bansal, Lisel Koepl, et al.
American Journal of Clinical Pathology|May 6, 2016
Clinical Experience With Modified, Single-Tube T-Cell Receptor Vβ Flow Cytometry Analysis for T-Cell ClonalityDavid Wu, Melanie M Anderson, Megan Othus, et al.
Bone Marrow Transplantation|August 27, 2022
Significance of measurable residual disease in adults with secondary acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantationEduardo Rodríguez-Arbolí, Corentin Orvain, Megan Othus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 8, 2012
Cure models as a useful statistical tool for analyzing survivalMegan Othus, Bart Barlogie, Michael L Leblanc, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 14, 2025
Designing Clinical Trials for Patients With Rare Cancers: Connecting the ZebrasVivek Subbiah, Megan Othus, Jim Palma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2020
Ipilimumab and Nivolumab in Rare Tumors S1609: Neuroendocrine-ResponseSandip P Patel, Megan Othus, Young Kwang Chae, et al.
Leukemia & Lymphoma|August 3, 2012
Influence of obesity on efficacy and toxicity of induction chemotherapy in patients with newly diagnosed acute myeloid leukemiaAndrew Lin, Megan Othus, Amy McQuary, et al.
Bone Marrow Transplantation|November 1, 2019
Statistics and measurable residual disease (MRD) testing: uses and abuses in hematopoietic cell transplantationMegan Othus, Robert Peter Gale, Christopher S Hourigan, et al.
International Journal of Radiation Oncology, Biology, Physics|July 8, 2010
Tumor volume is a prognostic factor in non-small-cell lung cancer treated with chemoradiotherapyBrian M Alexander, Megan Othus, Hale B Caglar, et al.
Pageof 24